EL
Nova Eye Medical Limited
ELXMF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $5.64M
P/E Ratio -
Div. Yield -
ROE 26.06%
Bulios Fair Price
$0.02
39.8% upside
Current Price
$0.014
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ELXMF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.16x
P/B 0.40x
P/E N/A
Growth
78 /100
Growing Rev. growth 26.93%
Book val. growth 14.97%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 71.74%
Net margin 12.43%
FCF margin 9.63%
Quality
15 /100
Poor ROIC 26.25%
ROE 26.06%
Asset turnover 1.62x
Debt
66 /100
Moderate Debt/Equity 0.17x
Current ratio 1.74x
Int. coverage -28.41x
Stability
76 /100
Stable Beta 0.93x
Rev. volatility 9.14%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ELXMF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Thomas Spurling
Employees
301
Headquarters
Kent Town
Upcoming events
02 MAR
Earnings
Upcoming earnings report